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Abstract 
The relationship between drug use and crime has been well-established in the literature 
among groups of illicit recreational substances. There is a paucity of literature investigating 
the misuse of prescribed pharmaceutical drugs and their contribution to the drug crime link. 
Benzodiazepines are a class of prescription anxiolytic drugs commonly used to treat anxiety. 
A small body of research suggests that the misuse of high potency benzodiazepines (e.g., 
alprazolam) can be positively associated with criminality. The current study aimed to 
examine the relationship between benzodiazepine use and criminal activity among a sample 
of 82 offenders. A case-crossover design was utilised whereby substance use in the 12-24 
hours prior to a crime event (hazard period) was compared with substance use in the 28 days 
prior to the same crime event (control period). Incidence Rate Ratios were calculated using 
multilevel mixed-effects negative binomial regression models to determine if there was an 
increased likelihood that benzodiazepine use in the hazard period was associated with 
criminal activity. After controlling for baseline alprazolam use, demographics, psychosocial 
factors, and general crime engagement, participants were 62% more likely to commit a crime 
if they had used alprazolam in the hazard period, IRR = 1.62, 95% CI [1.17-2.24], p = 0.003. 
There were non-significant positive associations between diazepam, other illicit substances 
and criminal activity and non-significant negative associations between methadone, 
temazepam, and criminal activity. These findings suggest there may be a strong and unique 
positive association between alprazolam use and criminal activity. This has important 
implications for individuals who are prescribed alprazolam or taking the drug recreationally 
within an offending population, as consumption may place them at greater risk for criminal 
engagement. This research also has implications for the ease of access to alprazolam 
prescriptions.  
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Benzodiazepine Use and Criminal Activity: A Case-Crossover Study 
The relationship between drug use and crime has been well-established in the 
literature among groups of illicit recreational substances (e.g., amphetamines, heroin, 
cocaine; Bennett, Holloway, & Farrington, 2008). A systematic review of drug use 
prevalence among prison populations found that illicit drug abuse and dependence were 
reported in 10%-48% of males and 30%-60% of females (Fazel, Bains, & Doll, 2006). 
Additionally, it was estimated that the societal cost of problematic drug and alcohol use in 
Australia for the 2004/2005 financial year was 23.5 billion dollars (Collins & Lapsley, 2008). 
Furthermore, of all prisoners incarcerated for violent crimes, approximately 24% of offences 
were attributable to illicit drug intoxication. Recent research has also indicated that there is a 
strong and positive association between the use of methamphetamines, heroin, and cannabis 
and acquisitive offending, due to an increased need to finance further drug use (Goldsmid & 
Willis, 2016). While it is difficult to establish a causal link between drug use and crime, some 
literature suggests the two may occur in parallel due to a third factor (e.g., a mental health 
condition; Seddon, 2000). For example, Swartz and Lurigio (2007) found that individuals 
who used substances alongside a diagnosis of a serious mental health condition were placed 
at an increased risk of being arrested for a crime. Attempting to investigate the acute triggers 
for drug use and associated crime will contribute to a better understanding of the drug-crime 
link. The majority of drug-crime literature has focussed on the use of illicit substances. There 
is currently a paucity of literature investigating the misuse of prescribed pharmaceutical 
drugs, like benzodiazepines, and their contribution to the drug-crime link.  
Drug Use and Offending Behaviour        
 A large body of existing literature suggests that individual’s dependent on illicit drugs 
are disproportionately involved in criminal activity; particularly acquisitive and property 
related offending (Pierce et al., 2015). The aetiological mechanisms involved in the drug-
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crime link remain unclear. Several theories have been posited in an attempt to explain the 
relationship between drug use and criminal behaviours. One of the most well-known theories 
is Goldstein’s (1985) tripartite framework, in which he specifies three ways that drug use and 
crime interact. Firstly, the forward causation component suggests drug use causes crime 
through either the need to fund further drug use or due to the physiological changes 
precipitated from the drug use itself (i.e., the individual becomes disinhibited; Bennet et al., 
2008). Secondly, the reverse causation component suggests that criminal involvement leads 
to drug use due to an increased opportunity to use drugs among crime circles (Hammersley, 
Forsyth, Morrison, & Davie, 1989). Lastly, the confounding component suggests there is no 
causal link between drug use and crime, rather they co-occur due to a common set of causes 
(i.e., a concomitant mental health condition, impulsivity, or socio-economic deprivation; 
Seddon, 2000). It is generally accepted among researchers that there is not a single sequential 
or causal relationship between drug use and criminality, but rather a complex association 
between the two (Gossop, Marsden, Stewart, & Rolfe, 2000). It is also accepted that the 
relationship between drug use and crime will vary between individuals due to individual 
differences, and within individuals over time due to changing situational factors (e.g., 
obtaining stable accommodation or being rehabilitated).      
 Although well known, the tripartite model has been criticised for lack of emphasis on 
the importance of psychological processes, social context, and the development of the drug-
crime relationship over time (Curtis & Wendel, 2007). In recent years the literature has 
refocused on understanding the patterns of involvement in drug use and crime separately, as 
opposed to just establishing a link between the two (Riordan, 2017). These recent theories 
suggest that certain individual traits underpin careers in drug use and crime (i.e., career 
criminals; DeLisi & Piquero, 2011). The criminal careers paradigm suggests that regardless 
of childhood experience (e.g., childhood impulse control; childhood propensity towards 
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crime) persistence and desistance towards criminality is shaped by the strength of meaningful 
social connections developed throughout life (DeLisi & Piquero, 2011). Protective factors 
like stable relationships, employment, and financial stability are seen to change the trajectory 
of criminal involvement in a positive way (Sampson & Laub, 2003). Sampson and Laub 
(2003) investigated the influence of alcohol and illicit substances on the criminal careers’ 
paradigm. Their findings suggested that over the course of a lifetime alcohol contributed to 
both persistent and episodic patterns of offending. They also found that alcohol and drug use 
undermined the strength of positive social connections with others, which contributed to 
further offending.   
 Acquisitive Offending. Historical research indicates that the regular and dependent 
use of drugs like heroin and cocaine is associated with income-generating crimes (e.g., 
acquisitive offending; Speckart & Anglin, 1985). The current study defines acquisitive 
offending as any offence that is committed to achieve a financial gain (Pierce et al., 2015). 
Jarvis and Parker (1989) found that heroin users were more likely to be charged with 
acquisitive offences to fund further heroin use over other types of crimes (e.g., assault, joy 
riding, and criminal damage). Additional studies have demonstrated that the onset of 
addictive drug use is also associated with an increased likelihood for criminal involvement 
which continues throughout the period of addiction (Ball, Shafter, & Nurco, 1983). 
Intoxication also seems to increase engagement in property-related offending (Sutherland et 
al., 2015).            
 A study conducted by Goldsmid and Willis (2016) investigated the criminal 
motivations of a group of Australian police detainees. Researchers compared results between 
detainees who used methamphetamines (n = 410) and those who did not (n = 736). The 
results indicated that those who used methamphetamines derived a significantly higher 
proportion of their income from crime than those who did not use. Logistic regression 
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analysis determined that methamphetamine, heroin, and cannabis use positively predicted 
engagement in acquisitive offences. Regression models also found that intoxication and 
funding further drug use played an integral role in the committing of property-related crimes. 
This research may have been compromised by detainees underreporting their involvement in 
crimes to avoid implicating themselves in offending that police were unaware of. Researchers 
also suggested the reported percentages of drug use were conservative estimates, due to 
participant social desirability bias.        
 Further studies have suggested that drug intoxication may contribute to engagement in 
violent crimes as well. Research has suggested that acquisitive crimes committed by drug 
users typically decrease following the implementation of drug treatment interventions. 
Perpetrators of violent crimes may differ from other drug-related offenders and have varied 
treatment needs due to contrasting criminal motivations. Given the significant societal impact 
that violent offences have on the community, understanding the criminal motivations and 
possible influence of drug use on violent offending is important.     
 Violent Offending. Violent crimes, including physical assault, homicide, 
manslaughter, violent sexual assaults, or serious threats cause significant harm to society. 
Violent offending is defined as any crime that utilises intentional force or power, threatened 
or actual, against another person, a group, a community, or property that has a high likelihood 
of resulting in injury, death, psychological harm, maldevelopment or deprivation (Krug, 
Mercy, Dahlberg, & Zwi, 2002). Research indicates that among substance using populations 
displaying criminal behaviours, a significant minority of deaths are caused by physical 
assault from others (Ericsson, Bradvic, & Håkansson, 2014). Violent crimes among this 
population are also known to be associated with various psychiatric problems including 
substance use disorder (Falk et al., 2014). Substance use disorder is also one of the strongest 
predictors of violence in early adulthood (Moberg et al., 2015). Additionally, amphetamines, 
BENZODIAZEPINE USE AND CRIME   13 
 
alcohol, and polysubstance use have been found to serve an important role in the commission 
of violent crimes. Further research investigating the mechanisms involved in this relationship 
is important, both to inform therapeutic intervention and aid in harm reduction to increase 
community safety.           
 A recent cohort study conducted by Pierce et al. (2017) investigated the relationship 
between opioid initiation and violent crimes. Participants were individuals who tested 
positive for opiate and cocaine metabolites as recorded by the Drug Test Record (DTR) 
between April 2005 and March 2009. Contrary to studies that have found an increase in 
violent crimes among opiate using populations, this study demonstrated a decrease in violent 
offending by men and no apparent increase in violent offences conducted by women after 
opioid initiation. These results are consistent with previous findings that revealed a null result 
between increased violence and opioid initiation, which may support the use of opioid 
replacement programs (i.e., Fiellin, Friedland, & Gourevitch, 2006; Parker & Auerhahn, 
1998; White & Gorman, 2000). Although the study contributes to important research about 
opioid initiation and crime, there was evidence of some misclassification between cases who 
tested positive to opioids and those who tested negative. This could have been attributed to 
the use of a saliva test, which only detects metabolites consumed in the 24 hours prior to 
testing. The saliva tests may not have detected less-problematic use and as such 
miscategorised opiate users as non-users, leading the results to be overly conservative.   
 Sommers and Baskin (2006) investigated the association between methamphetamine 
use and violence, by using life history interviews. The sample comprised of (N = 205) 
individuals who had used methamphetamines for a minimum of three months. Findings 
indicated that 26.8% of the sample had committed methamphetamine-related violence while 
intoxicated (i.e., 80 isolated reports of violence). Approximately 30% of males and 23% of 
females had engaged in violence while using methamphetamines. The study indicates that 
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methamphetamines have the potential to exacerbate an individual’s risk of violence while 
intoxicated. All interviewees agreed that methamphetamine use is associated with violence 
and abuse potential, however there was not a singular pattern of abuse trajectory among 
participants (i.e., the subjects experiences ranged from controlled use to addiction). Findings 
also suggested that while there is a heightened risk of violence when using 
methamphetamines, violence is not an inevitable outcome of methamphetamine abuse. 
Although providing an important contribution to drug-crime literature, consideration must be 
given to the impact of self-report bias on data collection as participants may have 
underreported their engagement in crime or substance use.  
Although the two preceding studies have conflicting findings, it may be a result of the 
different physiological changes precipitated by the two drug types (i.e., depressant versus 
stimulant) as opposed to their being a null relationship between some illicit drugs and violent 
crimes. These relationships may also be influenced by confounding factors (e.g., mental 
health conditions/polydrug use).  
Mental Health, Drug Use, and Criminality      
 Mental health issues have been implicated as another factor involved in the drug-
crime nexus. Historical literature has demonstrated a strong and positive association between 
mental health concerns and propensity to commit crimes, as manifested by overrepresentation 
in prison populations and higher arrest rates among individuals with mental health issues 
(Fazel & Danesh, 2002; Teplin, 1990). A 12-month prevalence study conducted by Butler et 
al. (2006) revealed that the Australian prison population had significantly higher psychiatric 
morbidity than the general population, 80% versus 31%, respectively. Although this indicates 
a clear positive relationship between mental health issues and offending behaviours, the 
underlying nature of this relationship is poorly understood. Despite this, the role of substance 
use is becoming more widely accepted (Junginger, Claypoole, Laygo, & Crisanti, 2006).   
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 Australian statistics indicate that among prisoners, illicit drug use is more common in 
individuals with high psychological distress than in individuals with low psychological 
distress (Forsythe & Adams, 2009). Illicit drug use is also more common among prisoners 
who are medicated for a mental health disorder (75%) as opposed to those who are not 
medicated (66%). Among prison entrants diagnosed with a mental health condition, nearly 
half disclosed their substance use contributed to their offending (Sweeney & Payne, 2012). 
When considering the increased prevalence of mental health conditions among prisoner 
populations, there has been an increased interest in the relationship between criminal activity 
and the misuse of prescribed pharmaceutical drugs, particularly benzodiazepines (Forsythe & 
Adams, 2009; Monheit, 2010).  
Benzodiazepines and Offending Behaviour  
Benzodiazepines are a type of prescription anxiolytic drug commonly used to treat  
anxiety and insomnia (Albrecht, Staiger, Hall, Kambouropoulos, & Best, 2016; Wain, Khong, 
& Sim, 2007). In Australia, there is an elevated rate of benzodiazepine prescribing, which is 
cause for concern given evidence of significant nonmedical use, abuse and other harm (Jones, 
Nielsen, Bruno, Frei, & Lubman, 2011). This also persists despite better long-term outcomes 
from psychological as opposed to pharmacological interventions (e.g., Baldwin et al., 2014; 
Gould, Ott, & Pollack, 1995; Yoon, Slade, & Fazel, 2017); and high rates of relapse 
following discontinuation of use (Morin, Belanger, Bastien, & Vallieres, 2005; Noyes, 
Garvey, Cook, & Suezler, 1991).         
 Although typically associated with sedative effects, benzodiazepines can be 
associated with paradoxical reactions including aggression, anger, and hostility (Jones et al., 
2011). While most single dose studies demonstrate low prevalence for these paradoxical 
effects, animal and human studies have demonstrated a positive correlation between 
benzodiazepine use and aggression (Wallace & Taylor, 2009). Specifically, Daderman and 
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Lidberg (1999) conducted a mixed methods study among a sample of male juvenile offenders 
(N = 19) and found that, flunitrazepam (rohypnol) and alcohol use was associated with 
planned grievous violence more severe than usual violent offending. The effects of 
flunitrazepam intoxication are largely associated with increased strength and self-esteem, 
reduced fear and insecurity (particularly related with punishment of violent acts), and a 
distorted sense of reality. As a result, researchers found that offenders had a reduced ability to 
experience anger, fear, and sadness, and had difficulty empathising with, or feeling 
guilt/remorse for their victims. Participants subjectively reported these side effects as 
desirable. These behaviours were observed in already violent individuals which may indicate 
that benzodiazepines exacerbate violent tendencies when used in conjunction with other 
substances. Particularly, benzodiazepines that are short-acting and are likely mediated by 
dose and environmental factors. The findings should be interpreted with some caution as 
there may be an increased risk of subjectivity and researcher bias impacting on the qualitative 
components of the results. Despite this, these paradoxical effects may further contribute to 
understanding the nature of the relationship between benzodiazepine use and criminality 
among offenders.   
 A longitudinal study conducted by Comiskey, Stapleton, and Kelly (2012) found that 
among a sample of inpatients and outpatients (N = 404), those who had not committed a 
crime at intake where eight times more likely to have committed an acquisitive crime at one 
year follow up if they were using benzodiazepines regularly. This level was higher than 
individuals who were regularly using cocaine. A further study found that among a group of 
individuals recently released from prison (N = 141) there was a strong and positive 
relationship between illicit benzodiazepine use and the commission of property crimes. 
National data has also found strong positive associations between benzodiazepine misuse and 
the occurrence of criminal activity (Fry, Smith, Bruno, O’Keefe, & Miller, 2007). Smith, 
BENZODIAZEPINE USE AND CRIME   17 
 
Miller, O’Keefe, and Fry (2007) investigated the relationship between benzodiazepine misuse 
and crime among injecting drug users in a Victorian sample. Results indicated that more than 
50% of the sample had engaged in property related crimes to procure the drug (e.g., 
burglaries, forged prescriptions). Property crimes were found to be most highly associated 
with the use of benzodiazepines (alprazolam) and heroin. Violent crimes were found to be 
most highly associated with benzodiazepines combined with another drug. Therefore, 
polydrug use including benzodiazepines may exacerbate violent tendencies.  
Benzodiazepines, Polysubstance use, and Offending Behaviours  
 Michel and Lang (2003) emphasised the importance of distinguishing between 
individuals who experience paradoxical reactions to benzodiazepines idiosyncratically and 
those who voluntarily seek disinhibition. Their research focussed on a sample of individuals 
who had consumed benzodiazepines and found that participants were more likely to 
voluntarily seek disinhibition. Researchers suggested it is unlikely that any benzodiazepine 
independently produces these adverse reactions; rather that dose, polysubstance use, and 
psychopathology interact to produce hazardous psychological states (Michel & Lang, 2003).  
 Specifically, alcohol seems to play an integral role in the onset of these paradoxical 
responses (Weerts & Miczek, 1996) due to the synergistic effects of alcohol and 
benzodiazepines on the central nervous system. Benzodiazepines have been known to have a 
great propensity to interact with alcohol, resulting in marked disturbances to psychomotor 
coordination (Kurzthaler et al., 2005). Other known side effects include reduced executive 
functioning (i.e., poor consequential thinking), memory loss, increased violence, inhibition of 
fear and disruption of threat detection resulting in increased risk-taking behaviours (de Geus, 
Denys, & Westenberg, 2007; Kurzthaler et al., 2005). Benzodiazepines can also impair 
episodic memory and metacognition, in that individuals have a reduced awareness of their 
own thought processes and behaviours. This could lead to the commission of crimes driven 
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by drug-induced memory failure. Some studies have also demonstrated that the combined 
effects of benzodiazepines and alcohol can trigger criminal activity (Haggard-Grann, 
Hallqvist, Langstrom, & Moller, 2006). Results indicated that individuals were approximately 
13 times more likely to engage in violent behaviours within 24 hours of alcohol and 
benzodiazepine use in high doses. Contrastingly, regular doses of benzodiazepines were 
associated with decreased criminality. This suggests that the regular and prescribed use of 
benzodiazepines may be protective. However, when individuals engage in polysubstance use 
and binging behaviours, they are placed at an increased risk of criminal engagement and 
exacerbation of violent tendencies (Michel & Lang, 2003). One benzodiazepine of interest is 
alprazolam, which when used recreationally can be associated with increased criminality 
(Albrecht, Staiger, Hall, Kambouropoulos, & Best, 2016).  
Alprazolam Use and Offending Behaviour  
 Alprazolam (Xanax) is a short acting benzodiazepine commonly prescribed to treat, 
anxiety, panic disorder, and depression (Hegel, Ravaris, & Ahles, 1994; RACGP, 2015; 
Verster & Volkerts, 2004). In recent years, the clinical use of alprazolam has been a point of 
contention, given the addictive nature of the drug, severe withdrawal syndrome, and its high 
potential for misuse (Ait-Daoud, Hamby, Sharma, & Blevins, 2018). Alprazolam remains to 
be one of the most commonly prescribed benzodiazepines. Examinations of United States 
national emergency department (ED) visit data from 2011 has found that alprazolam is the 
most common benzodiazepine to be involved in ED visits that are related to drug misuse 
(SAMHSA, 2013).  Historical research investigating the abuse liability of alprazolam has 
found that in comparison to other equipotent benzodiazepines (e.g., oxazepam), in individuals 
with a history of alcohol, opiate, or other drug dependence, alprazolam was preferred as the 
effects were more rewarding (Ciraulo et al., 1997). Similarly, in a small double-blind study 
(N = 14) among benzodiazepine users, alprazolam was preferred to diazepam in a drug choice 
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test (Apelt, Schmauss, & Emrich, 1990).        
 The high potential for abuse is thought to be attributed to the unique pharmacokinetic 
properties of the drug. Specifically, alprazolam has properties of rapid absorption, a short 
half-life, low lipophilicity, and high potency (Ait-Daoud et al., 2018). Like all addictive 
drugs, alprazolam alters the mesolimbic dopaminergic reward pathway in the brain. Some 
studies suggest that subjectively alprazolam produces more euphoria than other 
benzodiazepines (e.g., Iguchi et al., 1989). This may lend itself to increased risk of addiction 
when used for long periods of time. Independent evidence suggests that alprazolam may be 
associated with some unusual psychopharmacological effects in rats. Specifically, Bentue-
Ferrer et al. (2001) found that alprazolam uniquely affected the dopaminergic function of the 
striatum (e.g., a brain structure implicated in motivation and reward) in rats in a similar way 
to stimulants, despite being a depressant drug. This suggests that alprazolam has a unique 
ability to interact with the dopaminergic mesolimbic reward pathway. Based on this, the 
elevated level of benzodiazepine prescribing is cause for concern.     
 Albrecht et al. (2016) found that among a sample of reported benzodiazepine users, 
alprazolam predicted increased general and physical aggression. Anecdotal suggestions also 
indicate that alprazolam use is associated with increased criminality soon after use due to the 
high potency and short-acting nature of the drug (Rapaport & Braff, 1985), however little 
research has been conducted to this effect. Some studies have shown that alprazolam is 
associated with poor/risky decision making as well as novelty seeking on personality scales 
(e.g., Lane et al., 2005). Experimentally, there is some evidence to suggest that alprazolam is 
associated with increased aggression in humans (Bond, Curran, Bruce, O’Sullivan, & Shine, 
1995) and in mice (Votava et al., 2001) both on its own and when used in conjunction with 
alcohol (Bond & Silvieri, 1993). However, to date there is very little research examining the 
association between alprazolam use and criminal activity. The current study aims to rectify 
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this existing gap in the literature, by investigating the relationship between alprazolam misuse 
and criminality (i.e., acquisitive and violent) by way of case-crossover design.  
Current Study           
 There is a small body of literature suggesting that benzodiazepines, particularly high 
potency forms (e.g., alprazolam) are associated with criminality. However, the reasons for 
use and motives for offending remain to be fully investigated or understood. This is likely 
attributed to the difficulty in isolating the role of benzodiazepine use in a criminal population 
due to the increased presence of extraneous factors. For example, the presence of 
polysubstance use, engaging in criminal behaviours to fund further drug use, and 
demographic factors (e.g., low socio-economic status, psychological distress, social and 
familial context) may increase the likelihood of criminal involvement. By utilising a case-
crossover design, the relationship between benzodiazepine use and acute triggers for crime 
can be investigated while reducing the influence of extraneous factors, as participants act as 
their own controls. Case-crossover designs draw a comparison of exposures (i.e., 
benzodiazepine use) immediately prior to a hazardous event (i.e., crime) and a control event 
(i.e., general functioning). No research to date has utilised a case-crossover design to examine  
the relationship between benzodiazepine (alprazolam) use and crime among offenders.  
Aims and Hypotheses. The current study aimed to examine the effects of 
benzodiazepine use upon the occurrence of criminal activity. A case-crossover design was 
utilised with cases being a sample of offenders who use benzodiazepines. The study aimed to 
compare benzodiazepine use, specifically alprazolam in the 12-24 hours prior to a crime 
event (hazard period) with general alprazolam use (control period). Based on aforementioned 
research, the following predictions were made:       
 H1. Recent benzodiazepine use will be associated with the commission of a crime 
(i.e., greater odds of use in the hazard period than the control period).  
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H2. Alprazolam use in the hazard period will be more strongly associated with 
criminal activity than the use of other benzodiazepines in the hazard period.    
 H3. Recent other drug use will be associated with the commission of a crime in the 
hazard period over the control period.  
 H4. Alprazolam use in the hazard period will be associated with a greater likelihood 
of engagement in violent crimes over acquisitive crimes. It is not anticipated the same 
association will be seen in the use of other benzodiazepines.  
Method 
Participants 
Participants were recruited from various Drug Diversion Services at the Melbourne 
Magistrates Court (MMC) and Dandenong Drug Court (DDC) in metropolitan Victoria. The 
MMC offers two drug diversion programs including: 1) the Court Integrated Services 
Program which provides offenders with additional resources to reduce crime, and; 2) the 
Assessment and Referral Court List which is a specialist list of services designed to meet the 
needs of offenders who suffer from mental health issues or cognitive impairments. It should 
be noted that the commission of violent crimes as an index offence often render an offender 
ineligible to partake in drug diversion programs. Participants could also self-refer to the 
study.             
 Inclusion Criteria. Participants were required to be at least 18 years of age, have 
committed a crime within six months prior to the interview and used benzodiazepines at least  
once per month in the six months prior to the interview to partake in the study.   
The present study utilised an archival dataset of 82 offenders aged between 21–56 
years (Mage = 34.7, SDage = 6.96). Of the sample, the majority were male (79.3%), with 12.2% 
identifying as Aboriginal and 2.4% identifying as Torres Strait Islander. The majority of 
participants completed grades 7–9 (37.8%) and 10–11 (39.0%) of Highschool. Of the sample, 
BENZODIAZEPINE USE AND CRIME   22 
 
18.3% were homeless, 87.8% were unemployed and 11.0% engaged in criminal activity as a 
source of income. The majority of the recruited sample self-reported mental health concerns 
in the month prior to the crime event, with 82.9% of participants being diagnosed with a 
mental health condition. Depression (62.2%) and anxiety (43.9%) were among the most 
common mental health diagnoses experienced by participants. Bipolar (24.4%), panic 
disorder (20.7%), and short-term drug induced psychosis (22.0%) were also common among 
participants. Figure 1 displays the mental health profile of the recruited sample.   
 The majority of the sample (96.3%) had been engaged in Alcohol and Other Drug 
treatment programs in the past and 85.4% were engaged in drug treatment at the time of 
interview. Of those engaged in treatment, the majority were being treated for heroin use 
(62.2%), and only 2.4% were being treated for alprazolam use. Of those prescribed 
benzodiazepines, the majority used diazepam (78.0%) and temazepam (63.4%) correctly; 
whereas, alprazolam was used incorrectly by 58.5% of the sample.  
Figure 1. Mental Health Profile of the Recruited Sample. Note: *Obsessive Compulsive 





















Participant Mental Health Profile
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Approximately 63.4% of participants were diagnosed with two or more co-occurring 
mental health conditions. Figure 2 displays the number of mental health diagnoses 
experienced by participants.  
Figure 2. Number of Mental Health Diagnoses Experienced by Participants.  
Measures 
Criminality Scale of the Opiate Treatment Index (OTI; Darke, Ward, Hall, 
Heather, & Wodak, 1991). The criminality scale of the OTI assesses involvement in recent 
criminal activity across four crime areas: property crime, dealing, fraud, and violent crime 
(Darke et al., 1991). Respondents indicate on a 5-point Likert scale (ranging from 0 = No 
Crime to 4 = Daily), the frequency of engagement in each type of crime in the previous four 
weeks. Questions include ‘How often, on average, during the last month have you committed 
a property crime?’ (e.g., property crime) and ‘How often, on average, during the last month 
have you committed a crime involving violence?’ (e.g., violent crime). A total score is 
determined by summating all item responses from each of the four crime domains, whereby 
higher scores are reflective of more frequent crime engagement.     
 The measure demonstrates adequate psychometric properties. In terms of reliability, 
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al., 1991), internal consistency (Cronbach’s α = 0.86; Adelekan et al., 1996), and inter-rater 
reliability, ICC = 0.69, 95% CI [0.55-0.83] (González-Saiz & García-Valderrama, 2012). In 
terms of validity, the scale demonstrates adequate collateral validation with 76% agreement 
between partners on the property crime domain, 94% agreement between partners on the 
violent crime domain, 84% agreement between partners on the dealing domain, and 90% 
agreement between partners on the fraud domain (Darke et al., 1991). The measure also has 
adequate discriminant validity as evidenced by significant negative correlations (r = -0.45) 
with the Global Assessment of Functioning Scale (González-Saiz & García-Valderrama, 
2012).  
Severity of Dependence Scale (SDS; Gossop et al., 1995). The SDS is a five item 
self-report measure designed to assess the degree of dependence experienced by users of 
different types of drugs. Items are scored on a 4-point Likert scale (ranging from 0 = 
Never/Almost Never/Not Difficult to 3 = Always/Nearly Always/Impossible). Questions 
include ‘Did the prospect of missing a shot/snort make you very anxious or worried?’ and 
‘Did you ever think your use of (drug of choice) was out of control?’. The item content of the 
SDS reflects the psychological components of dependence (e.g., an individual’s lack of 
control over drug taking or preoccupations and anxieties about drug use). A total score is 
obtained by summating all item responses, whereby higher scores are reflective of a higher 
level of drug dependence (Gossop et al., 1995). In this study, the SDS was utilised to measure 
dependence to benzodiazepines, opioids, alcohol, and amphetamines in the four weeks prior 
to the crime event.  
The measure demonstrates adequate psychometric properties. In terms of reliability, 
the SDS has strong test-retest reliability, r = 0.88, and internal consistency (Cronbach’s 
α = 0.83; Martin, Copeland, Gates, & Gilmour, 2006). The SDS also has excellent inter-rater 
reliability (ICC < 0.75) across all total scores for alcohol, cannabis, crack cocaine, and 
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powder cocaine (Ferri et al., 2000). The construct validity of the SDS was also deemed as 
adequate using principal components analysis (PCA). A single factor structure was revealed 
for alcohol and cannabis, accounting for between 54.8% and 70% of the variance in the 
model (Ferri et al., 2000). The SDS also has strong concurrent validity, r = 0.80 when 
correlated with DSM-IV criteria (Martin et al., 2006).    
Timeline Follow Back (TLFB; Sobell & Sobell, 1992; Sobell, Brown, Leo, & 
Sobell, 1996). A 28-day TFLB method was utilised to measure engagement in substance 
using behaviours, criminal activity, and levels of psychological distress in the month prior to 
the index crime. A TLFB for the 24 hours prior to the index crime was also used to assess 
substance intoxication, substance withdrawal, and psychological distress in the hazard period. 
Two TLFB’s were collected to determine any significant differences between the hazard 
period and control period. This method allows for an interviewer to ask the participant to 
retrospectively estimate their drug use in the four weeks prior to the crime event. The tool is 
effective in obtaining a variety of qualitative estimates of drug use (Sobell et al., 1996). A 
sample question includes ‘What drugs were you regularly using in the month prior to the 
crime taking place?’.         
 Despite some concerns regarding the reliability of the TLFB method due to 
participants retrospective accounts of drug use and other behaviours, the tool has been widely 
validated across multiple settings. The measure has been sensitive to detecting changes in 
cannabis use and other drug use over time (Sobell et al, 1996). Among a sample of drug 
users, the measure demonstrated excellent test-retest reliability across three-time intervals 
(i.e., 30, 90, and 360 days prior to the time one interview), as evidenced by strong positive 
correlations, r = 0.75 to r = 0.96 (Robinson, Sobell, Sobell, & Leo, 2014). Among cannabis 
users, the tool demonstrated strong temporal stability when measuring the quantity of daily 
drug use, ICC = 0.83, and the frequency of drug use, ICC = 0.93 for the same 90-day period 
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between time one and time two (Norberg, Mackenzie, & Copeland, 2011). The tool also has 
excellent inter-rater reliability, ICC = 0.99 (Norberg et al., 2011). In terms of validity, the 
measure has adequate collateral validation, ICC = 0.92, 95% CI [0.88, 0.94] and convergent 
validity, r = 0.73. To measure divergent validity, the tool was correlated with scores on the 
Marlowe-Crowne Social Desirability Scale (MCSDS; Strahan & Gerbaski, 1972), and drug 
use was found to be non-significantly correlated, p < 0.66, with items relating to positive 
impression management (Norberg et al., 2011).   
Kessler (K-10) Psychological Distress Scale (Kessler et al., 2003). The K-10 is a 
10-item self-report measure designed to assess psychological distress in the previous four 
weeks. Items are scored on a 5-point Likert scale (ranging from 1 = None of the time to 5 = 
All of the time). Questions include ‘During the last 30 days, about how often did you feel 
nervous?’ and ‘During the last 30 days, about how often did you feel tired out of no good 
reason?’. A total score is obtained by summating all item responses, whereby higher scores 
are reflective of more severe psychological distress. Respondents are then categorised into 
one of three risk ranges depending on the severity of their anxious or depressive presentation: 
10 to 15 = low or no risk, 16 to 29 = medium risk, and 30 to 50 = high risk. For the current 
study, the K-10 was modified to measure psychological distress in the month following the 
crime event and improvement/deterioration in functioning during the hazard period (12-24 
hours prior to crime event) to identify psychological triggers for offending.   
 The K-10 has adequate psychometric properties. In terms of reliability, the measure 
has strong internal consistency (Cronbach’s α = 0.88; Ordinal α = 0.92; Sampasa-Kanyinga, 
Zamorski, & Colman, 2018), and test-retest reliability, ICC = 0.77, 95% CI [0.62, 0.86] 
(Ataei, Malek, & Shamshirgaran, 2015). In terms of validity, the K-10 has adequate 
convergent validity, r =0.63, 95% CI [0.62, 0.65], being significantly and positively 
correlated with both negative outcomes of distress and symptoms of DSM-IV mental 
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disorders. The measure also has adequate divergent validity, r = -0.60, 95% CI [-.062, -0.58], 
being significantly and negatively correlated with positive mental health symptoms 
(Sampasa-Kanyinga et al., 2018). The K-10 is effective in detecting psychological distress 
among distressed individuals (sensitivity = 86%; specificity = 83%; Sampasa-Kanyinga et al., 
2018). Interviewers also rated their confidence in the reliability of information being 
provided by participants as an additional measure of validity.  
Urgency, Premeditation, Perseverance and Sensation Seeking Scale (UPPS; 
Whiteside & Lynam, 2001). The UPPS is a 46 item self-report measure designed to assess 
impulsivity across four main dimensions: lack of premeditation, urgency, sensation seeking, 
and lack of perseverance (Whiteside & Lynam, 2001). Items are scored on a 4-point Likert 
scale (ranging from 1 = agree strongly to 4 = disagree strongly). Some items require reverse 
scoring. The mean of subscale scores is obtained and converted into a percentile rank 
whereby a higher percentile is indicative of greater impulsivity. Questions include ‘When I 
feel rejected, I will often say things that I later regret’ (e.g., urgency) and ‘I would enjoy 
water skiing’ (e.g., sensation seeking).   
The UPPS has adequate psychometric properties. In terms of reliability, the measure 
has strong internal consistency (Cronbach’s α = 0.88; Cyders, Littlefield, Coffey, & Karyadi, 
2014), and strong test-retest reliability across domains: lack of premeditation (r = 0.85), 
urgency (r = 0.87), sensation seeking (r = 0.92), and lack of perseverance (r = 0.85; Billieux 
et al., 2012). In terms of validity, the UPPS has strong divergent validity (r = 0.67) and 
convergent validity (r = 0.84; Whiteside, Lynam, Miller, & Reynolds, 2005). The UPPS also 
predicts impulsive externalising behaviours (e.g., substance use and antisocial behaviours), 
indicating the measure has adequate predictive validity. Confirmatory factor analysis has also 
confirmed a four-factor model of impulsivity, supporting the construct validity of the UPPS 
(Whiteside et al., 2005).  
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Procedure           
 The current study was promoted to Drug Diversion Services at the courts by using 
pamphlets and flyers. These were provided to services interested in partaking to gauge 
interest for study participants. Liaison with managers from these services allowed for 
efficient recruitment and on-site interviewing at courts administering drug treatment orders. 
Participants referred to the study (e.g., self-referral or service-referral) were screened for 
eligibility according to the inclusion criteria. Eligible participants engaged in structured open-
ended qualitative interviews by trained interviewers. Face-to-face and telephone interviews 
were conducted and lasted approximately 45-60 minutes. The index crimes were focussed on 
within participant interviews. All interviews were audio-recorded and transcribed verbatim.  
Design            
 The study utilised a case-crossover design. This design reduced the potential biases 
associated with recruiting different cases and controls as seen in conventional case-control 
studies (Wu & Anthony, 2000). An event-based approach was utilised in which participants 
substance use in the hazard and control period was compared. The hazard period refers to the 
12-24 hours prior to a crime event. This timeframe was selected, as the biological effects of 
most substances will occur within this period. The control period refers to the 28 days prior to 
the crime event. The crime event refers to the participants’ most recent conviction (index 
crime; refer to Figure 3 for a breakdown of the participant crime profile). The predictor 
variables were the type of drug consumed in the hazard and control period, and the outcome 
variable was engagement in a crime. Please refer to Table 1 for a breakdown of covariates, 
predictor, and outcome variables.        
 Statistical Analyses.  All analyses were planned a priori. Descriptive statistics were 
analysed using the IBM Statistical Package for the Social Sciences (SPSS) version 24.0. 
Incidence Rate Ratios were calculated using multilevel mixed-effects negative binomial 
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regression models using count data in STATA (the menbreg command in v15). These models 
included an assessment of length of exposure in order to recalibrate models to incorporate the 
difference in duration of hazard and control periods. Prior to analysis, one participant was 
removed from the dataset due to missing responses. A significance cut off of p < .05 was 
used in all analyses. 
 
 
Figure 3. Crime Profile of the Recruited Sample. Note: *person not present, **person 
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Table 1 
Predictor, Outcome, and Covariates for Analysis  
Predictor Variables Outcome Variable Covariates 
Alprazolam use Criminal Activity Age 
Temazepam use (index crime) Gender 
Diazepam use  Psychological Distress 
Methadone use  Impulsivity 
Heroin use  Intoxication 
Amphetamine use  Withdrawal 
Alcohol use  General Crime Engagement 
Cannabis use   
 
Results 
Descriptive Statistics        
 Frequency Analysis. The percentage of use for all drug variables in the hazard and 
control periods were examined via frequency analyses. As indicated in Table 2, 42.9% of 
participants endorsed using alprazolam in the hazard period and 57.1% of participants 
endorsed using alprazolam in the control period. Among those reporting alprazolam use, the 
drug was used on a median of 13 of the previous 28 days. The interquartile ranges among 
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Table 2.  
Frequency percentages, Median, and Interquartile Ranges for each Drug Variable  
Drug Type Hazard (%) Control (%) Days used in past month 
(among those that used) 
Interquartile 
Range (IQR) 
Alprazolam 42.9 57.1 13 24 
Diazepam 42.0 58.0 28 20 
Temazepam 18.2 81.8 4 24 
Amphetamines 20.5 79.5 4 6.5 
Heroin 42.1 57.9 28 20 
Methadone 45.3 54.7 28 0 
Cannabis 44.2 55.8 28 12 
Alcohol 40.2 59.8 14 20 
Note: (N = 82) 
Modelling associations between acute substance use and crime: Benzodiazepines  
The current study estimated the incidence rate ratio (IRR) for alprazolam, diazepam, 
and temazepam associated with the commission of a crime in the hazard period using crude 
and multivariate models. The multivariate analyses comprised of models with an increasing 
number of covariates (Table 3). The following covariates were included: model 1: 
demographic factors (age, gender); model 2: demographic factors, psychological distress, and 
impulsivity; model 3: demographic factors, psychological distress, impulsivity, intoxication, 
and withdrawal; and model 4: demographic factors, psychological distress, impulsivity, 
intoxication, withdrawal, and general crime engagement.      
 Alprazolam. The unadjusted (crude) IRR indicates that participants were 42% more 
likely to commit a crime if they had used alprazolam in the hazard period, although this result 
was not statistically significant, p = 0.120. The fully adjusted IRR was 1.62, 95% CI [1.17-
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2.24], p = 0.003, indicating that when controlling for demographics, psychosocial factors, and 
general crime engagement, participants were significantly more likely (62%) to commit a 
crime if they had used alprazolam in the hazard period.       
 Diazepam. The unadjusted (crude) IRR indicates that participants were 4% more 
likely to commit a crime if they had used diazepam in the hazard period, although this result 
was non-significant, p = 0.848. After controlling for all covariates, the IRR only slightly 
increased and remained non-significant, p = 0.606. This indicates that there is not a strong 
association between diazepam use and the commission of criminal activity in the current 
sample.          
 Temazepam. The unadjusted (crude) IRR indicates that participants were 4% more 
likely to commit a crime if they had used temazepam in the hazard period, although this 
result was non-significant, p = 0.971. After controlling for all covariates, the IRR decreased 
by approximately 40% and remained non-significant, p = 0.738. This indicates that in the 
current sample, temazepam use was not significantly associated with criminal activity in the 
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Table 3.  
Crude and Multivariate Incidence Rate Ratios for Alprazolam, Diazepam, and Temazepam 
(N = 82).  
 
Note: Model 1: demographic factors (age, gender); Model 2: demographic factors, 
psychological distress, impulsivity; Model 3: demographic factors, psychological distress, 
impulsivity, intoxication, withdrawal; Model 4: demographic factors, general crime 
engagement, psychological distress, impulsivity, intoxication, withdrawal.  
 
Modelling associations between acute substance use and crime: Other drug types   
 Findings from the models run for amphetamines, heroin, methadone, cannabis, and 
alcohol indicated that both the unadjusted and adjusted IRR’s were non-significant in all 
instances. The majority of these models indicated that drug use was associated with non-
significant increases in the likelihood crimes would be committed in the hazard period. 
Conversely, results demonstrated that methadone was uniquely associated with a decreased 
likelihood of criminal activity in the hazard period, although at non-significant levels. When 
controlling for basic demographic factors, cannabis was also associated with non-significant 
decreases in the likelihood of crime commission in the hazard period.   
 When controlling for demographic factors, psychological distress, and impulsivity in 
the amphetamine drug group, the multivariate models would not converge. The same was 
seen in the unadjusted model for cannabis. This may indicate that across these drug variables, 
there was not enough variation between the two time periods (e.g., hazard and control) for 
there to be a difference in results. 
 Alprazolam  Diazepam  Temazepam 
 IRR 95% CI p  IRR 95% CI p  IRR 95% CI p 
Crude 1.42 0.91-2.21 0.120  1.04 0.70-1.56 0.848  1.04 0.13-8.27 0.971 
Model 1 1.41 0.91-1.21 0.127  1.05 0.70-1.58 0.807  0.79 0.07-8.67 0.844 
Model 2 1.54 0.96-2.46 0.074  1.10 0.72-1.69 0.649  0.59 0.04-8.35 0.697 
Model 3 1.56 0.97-2.49 0.065  1.07 0.70-1.66 0.730  0.64 0.05-8.71 0.736 
Model 4 1.62 1.17-2.24 0.003**  1.12 0.73-1.72 0.606  0.64 0.05-8.97 0.738 
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Chi Square Analysis         
 There was insufficient power to analyse associations between substance use and crime 
separately for each crime type. A chi square test was conducted to assess whether alprazolam 
use was more highly associated with the commission of acquisitive or violent crimes. 
Alprazolam was used by 7 of the 11 people who engaged in violent crimes (i.e., 63%) and by 
28 of the 48 people who engaged in acquisitive crimes (i.e., 58%). As such, the results 
indicated that there was no significant difference between the two groups, 2 (3, 59) = 0.10, p 
= .747. This indicates that alprazolam use was not significantly associated with one crime 
type over another. However, this may be attributed to the limited power of the analysis given 
the small sample size (n = 59), rather than a null association.    
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Table 4.  





 Amphetamines  Heroin  Methadone  Cannabis  Alcohol 
 IRR 95% CI p  IRR 95% CI p  IRR 95% CI p  IRR 95% CI p  IRR 95% CI p 
Unadjusted 1.13 0.58-2.22 0.717  1.01 0.65-1.59 0.953  0.75 0.38-1.49 0.417  - - -  1.17 0.67-2.06 0.579 
Model 1 1.07 0.54-2.15 0.840  1.02 0.65-1.61 0.923  0.75 0.38-1.50 0.423  0.99 0.64-1.54 0.989  1.17 0.66-2.06 0.598 
Model 2 - - -  1.04 0.63-1.73 0.880  0.73 0.35-1.52 0.396  1.05 0.65-1.72 0.837  1.13 0.59-2.19 0.699 
Model 3 1.35 0.50-3.64 0.546  1.08 0.65-1.80 0.763  0.73 0.35-1.51 0.393  1.06 0.64-1.73 0.831  1.14 0.58-2.22 0.704 
Model 4 1.27 0.62-2.61 0.517  1.09 0.66-1.80 0.746  0.73 0.34-1.54 0.408  1.07 0.64-1.75 0.818  1.18 0.60-2.32 0.628 
Note: Model 1: demographic factors (age, gender); Model 2: demographic factors, psychological distress, impulsivity; Model 3: demographic factors, psychological 
distress, impulsivity, intoxication, withdrawal; Model 4: demographic factors, general crime engagement, psychological distress, impulsivity, intoxication, 
withdrawal.  
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Discussion 
 This study examined the relationship between substance use and criminal activity by 
way of case-crossover design among a sample of offenders. The role of benzodiazepine use, 
particularly alprazolam, in the relationship between drug use and crime was a key area of 
investigation.  
Benzodiazepine Use and Criminal Activity  
Diazepam and Temazepam. Contrary to predictions, diazepam and temazepam use 
was not associated with increased criminal activity. It was clear within the current sample 
that these benzodiazepines were associated with high levels of non-prescribed use; however, 
this was to a lesser degree than alprazolam. This may indicate that diazepam and temazepam 
have a lower abuse potential than other more potent benzodiazepines (e.g., alprazolam; Apelt 
et al., 1990). When using a drug as prescribed, individuals are less likely to experience 
addiction and dependence, which may place them at a reduced risk of engaging in criminal 
behaviours to fund further drug use. This finding may also support the notion that these 
benzodiazepines are not associated with the same paradoxical effects and disinhibition as 
seen in alprazolam use, which could further explain a null relationship with criminal activity. 
Based on the findings, this may support evidence suggesting diazepam and temazepam are a 
safer option for prescribing. Although, caution should be taken in prescribing to those with a 
substance use history, given they are still associated with misuse (Wain et al., 2007). Given 
the high levels of non-prescribed use in the current sample, future research could further 
investigate the relationship between varying doses of diazepam/temazepam and propensity to 
commit crimes. Specifically, if high doses (e.g., binging) or polysubstance use contribute to 
an increase in criminal activity.  
Alprazolam. Alprazolam use was found to be uniquely associated with the 
commission of criminal activity in the current study. The highly addictive nature of 
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alprazolam use has been consistently demonstrated within the literature (e.g., Ait-Daoud et 
al., 2018; SAMHSA, 2013). This study provides further evidence for the dangers associated 
with alprazolam use among offenders, particularly those with drug use histories who are 
susceptible to drug addiction and dependence.       
 There are a number of possible explanations for this relationship in the context of the 
drug-crime nexus. For example, continued alprazolam use could lead to 
addiction/dependence, subsequently prompting engagement in criminal behaviours to fund 
further drug use. This may be evidenced by the high proportion of acquisitive offending in 
the current sample. Alternatively, this could be explained by the unique paradoxical effects 
associated with the use of alprazolam. For example, individuals may have been disinhibited 
with a reduced capacity for decision making and an increased sense of novelty seeking after 
using the drug (Lane et al., 2005). This may be supported by the large proportion of 
individuals who used alprazolam prior to engaging in property crimes (e.g., 58%). This is 
supported by qualitative data, ‘One of the first times I took alprazolam I found myself with a 
bag full of shoplifting from a chemist which I couldn’t recall’. This could also be driven by 
drug-induced memory failure, given the impairing effects alprazolam use can have on 
metacognition. The study’s findings may also support the anecdotal suggestions that 
alprazolam use is associated with increased aggression in humans given 63% of individuals 
who engaged in violent crimes had used alprazolam in the hazard period. Furthermore, given 
the high level of mental health conditions in the current study it is possible that psychological 
vulnerabilities (outside of psychological distress which was controlled for) played a role in 
making individuals more susceptible to engaging in criminal activity and using drugs. This 
may be particularly important if alprazolam was prescribed for a mental health condition. 
When considering these explanations, the current findings have important clinical 
implications for health practitioners continuing to prescribe alprazolam.     
BENZODIAZEPINE USE AND CRIME   38 
 
 Given the current findings, adopting a universal precaution approach similar to that 
implemented for strong opioids (e.g., morphine; Monheit, 2010) is recommended, as 
alprazolam is also a schedule eight drug. This emphasises the importance of accurate 
assessment and diagnosis of substance use issues. In light of the current findings, universal 
precautions specific to alprazolam should also include a thorough assessment of the patient’s 
forensic history.           
 The following recommendations are made for health practitioners to adequately assess 
for substance use issues. Included in this assessment should be a thorough investigation of the 
patients’ prior pharmaceutical drug use and any associated drug use behaviours (e.g., 
binging). It is important for health practitioners to screen for a history of polysubstance use or 
engagement in current polysubstance use. Of major concern is the presence of alcohol or 
other depressant drug use. Not only is there an increased risk of lethal depressant drug use 
interactions, should alprazolam be consumed in conjunction with these substances, but the 
combination could increase the risk of disinhibition, aggression, and lead to a greater 
propensity to commit crimes (e.g., Bond & Silvieri, 1993). Long term substance use histories 
may have cognitive impacts as characterised by deficits in memory, decision-making, and 
impaired judgement. This could be further exacerbated if alprazolam is consumed, placing 
individuals at an increased risk for criminal involvement (Kurzthaler et al., 2005). This is 
supported by qualitative data , ‘I can’t even remember to tell you the truth; I woke up in the 
morning and found stupid things in my bag, like how can I put it, like things that wouldn’t 
mean anything, like I woke up with like 100 cups or something, stupid stuff’.   
 Of equal importance is ensuring the patients’ forensic history is adequately explored. 
Given the current findings were limited to a sample of offenders, it is not clear if these results 
could be generalised to a clinical population. Thus, the positive relationship between 
alprazolam and criminal activity could be attributed to factors that are more prevalent in an 
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offending population. For example, there is an increased prevalence of substance use, 
addiction, and dependence in forensic settings. Therefore, offenders may be at a greater risk 
of engaging in non-prescribed use that could lead to addiction and subsequent acquisitive 
offending. This cycle may be more prevalent in forensic rather than clinical settings. 
Offenders may be more susceptible to engaging in violent behaviours if they already have 
underlying aggressive tendencies. There may also be a higher prevalence of impulsivity and 
risk seeking behaviour in forensic settings. This could be exacerbated under the influence of 
alprazolam if intoxication leads to impairments in consequential thinking and subsequent 
engagement in crime. Additionally, unless working directly in a forensic setting or treating 
court mandated individuals, it can be difficult to ascertain whether the client/patient has a 
forensic history. If considering prescribing alprazolam, it is important to explore criminal 
history, as the presence of prior engagement in crime may place them at a greater risk for 
criminal involvement.          
 The current recommendations also support existing guidelines for the prescribing of 
alprazolam given it can be associated with disinhibition. For example, the Royal Australian 
College of General Practitioners (RACGP) have recommended the drug should be prescribed 
in low dosages and for short time periods only (e.g., between two and four weeks, with 
approval required after four weeks; RACGP, 2015). The British Association for 
Psychopharmacology (BAP) has also suggested, alprazolam is not considered a first line 
treatment option for anxiety. Alprazolam should only be prescribed if other psychological 
(e.g., Cognitive Behavioural Therapy, CBT) or pharmacological interventions are not 
successful (e.g., Selective Serotonin Reuptake Inhibitors (SSRIs); Baldwin et al., 2014).  
Given the dangers associated with alprazolam and other drug use, should a patient require a 
medication with calming effects, Seroquel may be more appropriate. Seroquel is not 
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associated with the same negative interactions with other opioids and alcohol, or the 
cognitive impairing effects seen in long term benzodiazepine use (de Geus et al., 2007).  
Other drug use and criminal activity  
This study did not find any significant associations between other illicit drug and 
alcohol use and criminal activity even after controlling for covariates. These findings were 
surprising given extant literature demonstrating positive associations between drug use and 
criminal engagement (e.g., Comiskey et al., 2012; Goldsmid & Willis., 2016; Pierce et al., 
2015; Sommers & Baskin., 2006). Interestingly, when examining the direction of the 
relationship between methadone use and crime, non-significant decreases were observed. 
Although non-significant, the decrease in crime is consistent with evidence in favour of 
methadone maintenance treatment programs (Fiellin et al., 2006). The benefits of methadone 
maintenance may also be supported by the non-significant increases in criminal activity 
following heroin use. Further examination of the relationship between opioid use, particularly 
methadone, and crime is warranted, especially if methadone treatment programs can help to 
reduce offending among opioid users.         
 No relationship between methamphetamine use, cannabis use, and crime was found in 
the current study. Although use was observed in the hazard period, the strength of the 
relationship was not enough to reach statistical significance. This contradicts the findings of 
Goldsmid and Willis (2016) who positively predicted engagement in acquisitive crime 
following methamphetamine or cannabis use; and Sommers and Baskin (2006) who found 
strong positive associations between intoxication and methamphetamine-related violence. 
The current findings support the notion that there is not a single pattern of abuse trajectory 
(Sommers & Baskin, 2006) and although theoretical models suggest drug use may place 
individuals at an increased risk for criminal involvement, this is not an inevitable outcome. 
This result could also be explained by the characteristics of the current sample, in that there 
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was a high proportion of substance use. There may be a higher likelihood of observing an 
association between drug use and crime or an increased frequency of crime in a general 
population of people or offenders.        
 When considering alcohol, previous research consistently indicates there is a positive 
association between consumption and criminal activity (Haggard-Grann et al., 2006; 
Kurzthaler et al., 2005; Weerts & Miczek, 1996). This is evident when consuming alcohol in 
combination with other substances, particularly benzodiazepines, due to the presence of 
depressant interactions. Current findings do not support this as no relationship was found 
between alcohol use and crime. Given previous studies have spoken to the dangers associated 
with combining alcohol and benzodiazepines (e.g., Weerts & Miczek, 1996) further 
examination of the interplay between alcohol, alprazolam use and crime is important.   
Alprazolam Use: Violent and Acquisitive Offending   
The current findings did not support predictions regarding alprazolam use being more 
highly associated with violent crime. The small body of research examining the relationship 
between alprazolam and criminal activity has found that those who experience the 
paradoxical effects of the drug are more likely to express aggression and violence. This could 
precipitate engagement in violent offences (Albrecht et al., 2016). This is supported by 
qualitative data, ‘I’ve never really been too violent but at a time when I took Rivotril and 
Alprazolam together the next day I know my girlfriend at the time, I think she threw away my, 
the other Rivotril I had left over for the next day and that made me so angry that I trashed my 
own apartment… the police were called and I was acting really irrationally and I ended up 
getting capsicum sprayed and arrested for the night’. Therefore, it is surprising that although 
alprazolam use in the current sample was significantly associated with increased likelihood of 
criminal engagement, it was not more highly associated with violent crimes over other types 
of acquisitive offences. It is thought this finding could be attributed to methodological 
BENZODIAZEPINE USE AND CRIME   42 
 
weaknesses rather than a true null result. For example, as participants were recruited from 
Drug Diversion Services that prohibited violent offenders from engaging in treatment, there 
was a large disproportion between the quantity of violent and acquisitive offences in the 
sample. Thus, there was not enough power in the sample to investigate the relationship 
between alprazolam the two types of crime (i.e., violent and acquisitive) separately. If violent 
offenders were more represented in the sample, and there was greater power to investigate the 
relationship between alprazolam use and violent crime, the results may have been consistent 
with the findings of Albrecht and colleagues (2016).   
Clinical Relevance           
 The current study has important clinical implications for offenders who use 
alprazolam and for clinicians and health professionals who prescribe the drug in those with 
substance use and forensic histories. Although there is evidence in the literature that suggests 
alprazolam is effective in treating anxiety and related conditions (Verster & Volkerts, 2004), 
there is also significant evidence suggesting alprazolam use can be associated with rebound 
anxiety following discontinuation of use. Alprazolam use is associated with withdrawal 
syndrome more severe than other benzodiazepines, even after following guidelines to taper 
doses (Ait-Daoud et al., 2018). When considering this, in combination with the findings of 
the current research which provide strong evidence for alprazolam’s association with 
engagement in crime, other treatment options should be considered for anxiety disorders.  
 Psychological interventions such as CBT have been consistently found to be 
associated with long-term reductions in anxiety. Comparatively, CBT is associated with 
smaller rates of relapse than benzodiazepines when used to treat anxiety and insomnia (Morin 
et al., 2005; Noyes et al., 1991). Other psychological interventions such as mindfulness and 
behavioural approaches (e.g., exposure therapy) are associated with positive treatment 
outcomes for anxiety (Yoon et al., 2017). The absence of physical side effects and 
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withdrawal symptoms also support the benefits of psychological interventions for anxiety. 
Health care providers should consider referring patients to seek psychological support for 
anxiety as an alternative to benzodiazepine treatment. This is important if the individual has a 
substance use or forensic history. Combining psychological interventions and alprazolam has 
been efficacious in treating anxiety and panic disorder (e.g., Hegel et al., 1994). Despite this, 
in light of the current findings, and addictive nature of alprazolam, caution should be used 
prior to prescribing the drug as it could lead to increased engagement in crime. Should a 
combined psychological and pharmacological approach be preferred, consideration should be 
given to other less potent benzodiazepines (e.g., diazepam) or other medical options (e.g., 
SSRI’s) that are less associated with criminal behaviour (Balwin et al., 2014).   
 The current findings shed light on the unique risks associated with alprazolam use. It 
is important not only to consider restricting access to the drug by way of prescription, but 
also for the development of alprazolam specific treatment programs. This could entail aiding 
individuals in safely detoxing, managing rebound anxiety/panic through the use of relaxation 
or other cognitive behavioural approaches (e.g., thought challenging, interoceptive exposure), 
developing strategies to manage cravings associated with addiction or dependence, and 
monitoring safe alprazolam use. Embedded within such a program is the importance of 
psychoeducational components about the abuse and criminal engagement risks associated 
with the use of alprazolam. Further research into the development of such a program is 
warranted, given the high rates of continued alprazolam misuse.  
Limitations and Future Direction        
 There are limitations in the current research that need to be considered when 
interpreting the results. The small sample size and limited power of the study yielded several 
disadvantages in terms of the types of analyses that could be conducted. Firstly, only single 
drug types could be examined in the binomial regression models, as there was not enough 
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power in the sample to examine interactions between drug types. This was a noteworthy 
limitation as there are clear links in the literature between the use of alprazolam in 
conjunction with other drugs (e.g., alcohol) and engagement in criminal activity (e.g., 
Haggard-Grann et al., 2006). There was strong evidence of polydrug use in the current 
sample. The role of polydrug use in the relationship between alprazolam and crime could not 
be further investigated. Despite this, the current findings strongly support the unique positive 
relationship between alprazolam misuse and criminal engagement.    
 Secondly, significantly more participants committed acquisitive crimes in the current 
sample than violent crimes, 58.5% versus 13.4% respectively (i.e., note the proportion of the 
sample involved in other types of crime, for example failing to appear in court). This is likely 
because a primary recruitment source was through drug diversion programs, whereby violent 
crimes render the offender ineligible to participate. Additionally, due to the limited power of 
the sample, it was difficult to differentiate whether alprazolam or other drug use was more 
strongly associated with acquisitive or violent offending using binomial regression models. 
Further studies should endeavour to recruit a larger sample with a more balanced spread of 
crime types to overcome this limitation.        
 Thirdly, some drugs showed little variation in the models across the two time periods 
(e.g., cannabis). This is likely the result of the recruited sample being a heavy drug using 
population, whereby drug use behaviours are generally consistent. Thus, there may have been 
some difficulty in distinguishing the hazard period from the control period (e.g., general drug 
use) for drugs like cannabis, when participants were using every day. The current study could 
have benefited from recruiting participants from a more general crime population rather than 
predominantly through drug diversion programs.       
 Fourthly, the findings of the current study are limited to only those in an offending 
population. The results cannot be generalised to individuals who use alprazolam in non-crime 
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populations as the recruited sample consisted only of those individuals who had committed 
an offence. Further research should endeavour to investigate the relationship between 
alprazolam use and propensity to commit crimes among individuals prescribed or using 
alprazolam in the general population. Despite this, the current study has demonstrated strong 
findings among a crime population. Although, further research is warranted, the results 
provide continued support for the literature advising against the prescribing of alprazolam, 
particularly among those with substance use histories.     
 Finally, there are some limitations associated with the use of a TLFB method among 
substance using populations. The efficacy of this method has been demonstrated in cannabis 
users (Sobell et al, 1996). However, there are some concerns regarding retrospective accounts 
of substance use behaviours for drugs like benzodiazepines and alcohol when there is a delay 
between the incident and the time of interview. This may be attributed to the cognitive 
impacts that repeated use of drugs has on cognitive functioning, attention, and memory 
(Kurzthaler et al., 2005). When considering a common side effect of alprazolam use is 
disinhibition, it is likely that possible memory impairment is associated with this. To account 
for this, the current study utilised an inbuilt validity measure, whereby interviewers rated 
participants quality of recall on a Likert type scale from zero to ten. This data was only 
gathered for 19.5% of the participants interviewed. Of the quality of recall data that was 
collected, 87.7% of participants were rated as having a quality of recall above six. Due to the 
small percentage of participants who were rated on recall ability, it cannot be concluded that 
participant recall was accurate and did not methodologically impair the study results. 
Therefore, the results should be interpreted with caution.     
 Despite these caveats, the current study was effectively able to establish strong links 
between the misuse of alprazolam and criminal involvement and has a number of noteworthy 
strengths. For example, multiple benzodiazepines, pharmaceutical opioids, and illicit drugs 
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were explored, allowing for a broader investigation of the drug-crime link. The study design 
allowed for the unique observation of the relationship between drug use and crime while 
controlling for the influence of extraneous factors. Finally, this is the first study to our 
knowledge specifically examining the link between alprazolam use and  
criminal activity using a case-crossover design.  
Conclusion  
 The current study builds on the small body of literature indicating that the possible 
acute paradoxical effects or disinhibition associated with alprazolam use is linked with an 
increased likelihood for criminal involvement. The high potential for alprazolam abuse and 
unique association with criminal activity has important implications for health care providers 
prescribing alprazolam for anxiety or related conditions. This study highlights the importance 
of the short term prescribing of the drug, particularly if addiction, abuse, or disinhibition lead 
to engagement in criminal activity after use. The importance of a thorough assessment of the 
patients’ substance use and forensic history, in light of the current findings is paramount. This 
study provides further encouragement for the use of psychological interventions such as CBT 
in the treatment of anxiety, particularly as a safe alternative to those who may present within 
a forensic setting or have difficulties with substance use. Further investigation into the 
development of an alprazolam specific treatment program to aid individuals in safely 
managing cravings, detoxing, and monitoring alprazolam use is recommended. The anti-
anxiety properties of alprazolam are outweighed by the high likelihood of abuse, increased 
potential for criminal engagement, and possible risks posed to community safety in those who 
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